The use of real-time quantitative PCR to detect circulating prostate-specific membrane antigen mRNA in patients with prostate carcinoma

Annals of the New York Academy of Sciences

Volumn 1022, Issue , 2004, Pages 157-162

  Chu, Da Chang ^a,b   Chuang, Cheng Keng ^b   Liou, Yi Fang ^a   Tzou, Ron Dar ^b   Lee, Hsiao Chun ^a   Sun, Chien Feng ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Nested PCR; Noninvasive molecular diagnosis; Prostate cancer; Prostate specific membrane antigen (PSM); Real time quantitative PCR

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

BLOOD SAMPLING; CANCER DIAGNOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 3242664152     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1318.026     Document Type: Conference Paper

References (7)

1. MERRILL, R.M. & J.L. LYON. 2000. Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology 55: 730-735.
2. Bulletin board, Department of Health, Taiwanese government, 2003.
3. LEE, F. et al. 1988. Prostate cancer: comparison of transrectal US and digital examination for screening. Radiology 168: 389-394.
4. SCARDINO, P.T. 1989. Early detection of prostate cancer. Urol. Clin. N. Amer. 16: 635-655.
5. WU, J.T. et al. 1998. Monitoring percent free PSA in serial specimens: improvement of test specificity, early detection, and identification of occult tumors. J. Clin. Lab. Anal. 12: 26-31.
6. NOGUCHI, M. et al. 1997. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction. Int. J. Urol. 4: 374-379.
7. CHANG, S.S. et al. 2000. Short-term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues. Cancer 88: 407-415.